Open label phase II trial of single, ascending doses of MRA in Caucasian children with severe systemic juvenile idiopathic arthritis: proof of principle of the efficacy of IL-6 receptor blockade in this type of arthritis and demonstration of prolonged clinical improvement

Woo, P., Wilkinson, N., Prieur, A-M., Southwood, T., Leone, V., Livermore, P., Wythe, H., Thomson, D. and Kishimoto, T. (2005) Open label phase II trial of single, ascending doses of MRA in Caucasian children with severe systemic juvenile idiopathic arthritis: proof of principle of the efficacy of IL-6 receptor blockade in this type of arthritis and demonstration of prolonged clinical improvement. Arthritis Research and Therapy, 7 (6). ISSN 1478-6354
Copy
Item Type Article
Identification Number 10.1186/ar1826
Additional information This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/ 2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Original article can be found at: http://arthritis-research.com/
Date Deposited 15 May 2025 11:43
Last Modified 08 Apr 2026 19:52

Explore Further

picture_as_pdf
901524.pdf
View Download

EndNote BibTeX Reference Manager Refer Atom Dublin Core RIOXX2 XML MODS OPENAIRE ASCII Citation METS Data Cite XML OpenURL ContextObject in Span HTML Citation OpenURL ContextObject MPEG-21 DIDL
Export

Downloads